TY - JOUR
KW - Analgesics, Opioid
KW - COVID-19
KW - Humans
KW - Methadone/therapeutic use
KW - policy
KW - Rural Population
KW - SARS-CoV-2
KW - United States
KW - addiction medicine
KW - Methadone
KW - Qualitative Research
KW - rural
KW - Substance-related disorder
AU - X. A. Levander
AU - K. A. Hoffman
AU - J. W. McIlveen
AU - D. McCarty
AU - J. P. Terashima
AU - P. T. Korthuis
A1 - 
AD - Division of General Internal Medicine & Geriatrics, Department of Medicine, Addiction Medicine Section, Oregon Health & Science University, 3181 SW Sam Jackson Park Road Mail Code - L475, Portland, OR, 97239-3098, USA. levander@ohsu.edu.; Oregon Health & Science University-Portland State University School of Public Health, Portland, OR, USA.; Oregon Health Authority State Opioid Treatment Authority, Salem, OR, USA.; Oregon Health & Science University-Portland State University School of Public Health, Portland, OR, USA.; Department of Psychiatry, Yale University, New Haven, CT, USA.; Division of General Internal Medicine & Geriatrics, Department of Medicine, Addiction Medicine Section, Oregon Health & Science University, 3181 SW Sam Jackson Park Road Mail Code - L475, Portland, OR, 97239-3098, USA.; Oregon Health & Science University-Portland State University School of Public Health, Portland, OR, USA.
BT - Addiction science & clinical practice
C5 - Education & Workforce; Financing & Sustainability; Healthcare Disparities; Opioids & Substance Use
CP - 1
DO - 10.1186/s13722-021-00281-3
IS - 1
JF - Addiction science & clinical practice
LA - eng
M1 - Journal Article
PB - . The Author(s)
PY - 2021
SN - 1940-0640; 1940-0632; 1940-0632
SP - 72
T1 - Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis
T2 - Addiction science & clinical practice
TI - Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis
U1 - Education & Workforce; Financing & Sustainability; Healthcare Disparities; Opioids & Substance Use
U2 - 34895346
U3 - 10.1186/s13722-021-00281-3
VL - 16
VO - 1940-0640; 1940-0632; 1940-0632
Y1 - 2021
Y2 - Dec 11
ER -